AKT1 and colorectal carcinoma: Due to the pivotal role of PI3K/Akt/mTOR pathway in CRC, more researches have focused on the natural and synthetic small molecules that can effectively target this pathway as potent inhibitors of CRCs (Bahrami et al. 2018).